PHASE-I TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND 5-FLUOROURACIL (CEF) FOR STAGE-II BREAST-CANCER

被引：0
|
作者：
JONES, SE
MENNEL, RG
PETERS, GN
WESTRICK, MA
BROOKS, BD
KNOX, SM
MCGUFFEY, P
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 198
页数：4
相关论文
共 50 条
  • [1] Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma
    Hiroji Iwata
    Seigo Nakamura
    Masakazu Toi
    Eisei Shin
    Norikazu Masuda
    Shinji Ohno
    Yuichi Takatsuka
    Kazufumi Hisamatsu
    Kosuke Yamazaki
    Mikihiro Kusama
    Hiroshi Kaise
    Yasuyuki Sato
    Katsumasa Kuroi
    Futoshi Akiyama
    Hitoshi Tsuda
    Masafumi Kurosumi
    Breast Cancer, 2005, 12 (2) : 99 - 103
  • [2] ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    RIVKIN, S
    GLUCKSBERG, H
    RASMUSSEN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 353 - 353
  • [3] 2 YEARS OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL AS ADJUVANT CHEMOTHERAPY FOR STAGE-II AND STAGE-III BREAST-CARCINOMA
    CACERES, E
    VALDIVIA, S
    COTRINA, M
    LINGAN, M
    LEON, L
    GAMBOA, M
    OLIVARES, L
    MORAN, M
    JOURNAL OF SURGICAL ONCOLOGY, 1988, 39 (03) : 169 - 174
  • [4] ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN STAGE-II OR STAGE-III BREAST-CANCER 5-YEAR RESULTS
    BUZDAR, AU
    BLUMENSCHEIN, GR
    LEGHA, SS
    HORTOBAGYI, GN
    YAP, HY
    SMITH, TL
    HERSH, EM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 144 - 144
  • [5] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE OR CMF IN PREMENOPAUSAL WOMEN WITH STAGE-II BREAST-CANCER
    BRINCKER, H
    MOURIDSEN, HT
    ANDERSEN, KW
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (01) : 91 - 95
  • [6] ON THE SAFETY OF PERIOPERATIVE ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL IN BREAST-CANCER
    RUDENSTAM, CM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08): : 1305 - 1308
  • [7] Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
    Jamieson, David
    Lee, Jo
    Cresti, Nicola
    Jackson, Rosanna
    Griffin, Melanie
    Sludden, Julieanne
    Verrill, Mark
    Boddy, Alan V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 667 - 674
  • [8] Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
    David Jamieson
    Jo Lee
    Nicola Cresti
    Rosanna Jackson
    Melanie Griffin
    Julieanne Sludden
    Mark Verrill
    Alan V. Boddy
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 667 - 674
  • [9] Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil)
    Tsavaris, N
    Kosmas, C
    Vadiaka, M
    Sougioultzis, S
    Kontos, A
    Agelopoulou, A
    Boulamatsis, D
    Koufos, C
    JOURNAL OF CHEMOTHERAPY, 2001, 13 (06) : 641 - 647
  • [10] A PRELIMINARY-REPORT OF A PILOT RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL WITH CYCLOPHOSPHAMIDE, MITOXANTRONE AND 5-FLUOROURACIL IN THE ADJUVANT THERAPY OF STAGE-II BREAST-CANCER WITH 4 OR MORE POSITIVE AXILLARY NODES
    ISACSON, R
    SAFRA, T
    BENDOR, CG
    UZIELY, B
    BRUFMAN, G
    ANTI-CANCER DRUGS, 1993, 4 (02) : 189 - 192
12345